Stockscreener 앱 받기
2.52
7.35%
-0.20
시장 영업 전:
2.46
-0.06
-2.38%
전일 마감가:
$2.72
열려 있는:
$2.71
하루 거래량:
23,351
Relative Volume:
0.17
시가총액:
$103.53M
수익:
-
순이익/손실:
$-7.92M
주가수익비율:
-8.40
EPS:
-0.3
순현금흐름:
$-7.05M
1주 성능:
+8.15%
1개월 성능:
+1.20%
6개월 성능:
+142.31%
1년 성능:
+33.33%
1일 변동 폭
$2.52
$2.7376
1주일 범위
$2.26
$2.7376
52주 변동 폭
$0.8001
$3.39
아네불로 파마슈티컬 Stock (ANEB) Company Profile
명칭
Anebulo Pharmaceuticals Inc
전화
737 203 5270
주소
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
ANEB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.52 | 101.07M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
아네불로 파마슈티컬 주식(ANEB)의 최신 뉴스
Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flows2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
What is the fair value of Anebulo Pharmaceuticals Inc. stock nowPortfolio Return Summary & Expert-Curated Trade Recommendations - newser.com
Is Anebulo Pharmaceuticals Inc. stock resilient to inflationEarnings Trend Report & Verified Short-Term Trading Plans - newser.com
Advanced analytics toolkit walkthrough for Anebulo Pharmaceuticals Inc.Trade Entry Summary & Precise Buy Zone Identification - newser.com
Why Anebulo Pharmaceuticals Inc. stock could see breakout soon2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
What technical charts say about Anebulo Pharmaceuticals Inc. stock2025 Market Outlook & Weekly High Momentum Picks - newser.com
Tick level data insight on Anebulo Pharmaceuticals Inc. volatilityEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Will Anebulo Pharmaceuticals Inc. outperform the marketFed Meeting & Risk Managed Investment Strategies - newser.com
Will Anebulo Pharmaceuticals Inc. price bounce be sustainablePrice Action & Reliable Price Breakout Signals - newser.com
Published on: 2025-10-13 07:20:43 - newser.com
Price action breakdown for Anebulo Pharmaceuticals Inc.M&A Rumor & Real-Time Volume Trigger Notifications - newser.com
Measuring Anebulo Pharmaceuticals Inc.’s beta against major indices2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Anebulo approves reverse stock split ahead of going-private transaction - MSN
Is Anebulo Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Breakouts & Capital Protection Trading Alerts - newser.com
Does Anebulo Pharmaceuticals Inc. qualify in momentum factor screeningEarnings Miss & High Return Trade Opportunity Guides - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Anebulo Pharmaceuticals (NASDAQ:ANEB) - MarketBeat
What drives Anebulo Pharmaceuticals Inc stock priceHigh Beta Stocks & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Can Anebulo Pharmaceuticals Inc. recover in the next quarterJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Anebulo Pharmaceuticals Inc. stock trendline breakdownJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
Regression analysis insights on Anebulo Pharmaceuticals Inc. performanceSell Signal & Smart Allocation Stock Tips - newser.com
What institutional flow reveals about Anebulo Pharmaceuticals Inc.Trade Risk Report & Capital Efficiency Focused Ideas - newser.com
Can Anebulo Pharmaceuticals Inc. stock attract ESG capital inflowsPrice Action & Stock Market Timing Techniques - newser.com
Can Anebulo Pharmaceuticals Inc. stock continue upward trendWeekly Market Summary & Comprehensive Market Scan Insights - newser.com
We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely - Yahoo Finance
Visualizing Anebulo Pharmaceuticals Inc. stock with heatmapsGap Down & Fast Entry and Exit Trade Plans - newser.com
Will breakout in Anebulo Pharmaceuticals Inc. lead to full recoveryJuly 2025 Sector Moves & Growth Focused Stock Reports - newser.com
Does Anebulo Pharmaceuticals Inc. fit your quant trading model2025 EndofYear Setup & Community Consensus Trade Alerts - newser.com
Goldman Sachs Group Inc. Invests $62,000 in Anebulo Pharmaceuticals, Inc. $ANEB - Defense World
아네불로 파마슈티컬 (ANEB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.96%
0.09%
자본화:
|
볼륨(24시간):